• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Toll样受体与动脉粥样硬化:氧化型低密度脂蛋白作为内源性Toll样受体配体

Toll-like receptors and atherosclerosis: oxidized LDL as an endogenous Toll-like receptor ligand.

作者信息

Miller Yury I

机构信息

Department of Medicine, University of California, San Diego, USA.

出版信息

Future Cardiol. 2005 Nov;1(6):785-92. doi: 10.2217/14796678.1.6.785.

DOI:10.2217/14796678.1.6.785
PMID:19804052
Abstract

The oxidation hypothesis of atherosclerosis suggests that oxidative modification of low-density lipoprotein (LDL) is a prerequisite for LDL atherogenicity. Recent studies demonstrate that upon oxidative modification, LDL becomes enriched with pathogen-associated molecular patterns recognized by natural (inborn) antibodies and innate immune receptors. This review focuses on recent findings showing that Toll-like receptors (TLRs)--which sense microbial pathogens and initiate immediate inflammatory responses--are potentially involved in the pathogenesis of atherosclerosis. In addition to the data that bacterial agonists of TLR4 and TLR2 accelerate atherosclerosis, new evidence suggests that minimally oxidized LDL and specific oxidized phospholipids signal via TLRs to induce cytoskeletal changes and inflammatory cytokine secretion by macrophages and endothelial cells. Identifying the signaling mechanisms by which oxidized LDL induces chronic inflammation in atherosclerotic lesions may lead to novel therapeutic targets for the treatment of atherosclerotic cardiovascular disease.

摘要

动脉粥样硬化的氧化假说表明,低密度脂蛋白(LDL)的氧化修饰是LDL致动脉粥样硬化性的先决条件。最近的研究表明,在氧化修饰后,LDL富含天然(先天)抗体和先天免疫受体所识别的病原体相关分子模式。本综述重点关注最近的研究结果,这些结果表明,可感知微生物病原体并引发即时炎症反应的Toll样受体(TLR)可能参与动脉粥样硬化的发病机制。除了TLR4和TLR2的细菌激动剂可加速动脉粥样硬化的数据外,新证据表明,轻度氧化的LDL和特定的氧化磷脂通过TLR发出信号,以诱导巨噬细胞和内皮细胞的细胞骨架变化和炎性细胞因子分泌。确定氧化LDL在动脉粥样硬化病变中诱导慢性炎症的信号传导机制,可能会为动脉粥样硬化性心血管疾病的治疗带来新的治疗靶点。

相似文献

1
Toll-like receptors and atherosclerosis: oxidized LDL as an endogenous Toll-like receptor ligand.Toll样受体与动脉粥样硬化:氧化型低密度脂蛋白作为内源性Toll样受体配体
Future Cardiol. 2005 Nov;1(6):785-92. doi: 10.2217/14796678.1.6.785.
2
Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.氧化型低密度脂蛋白抗体:心血管疾病的流行病学研究及潜在临床应用
Minerva Cardioangiol. 2007 Dec;55(6):821-37.
3
Oxidized low density lipoprotein and innate immune receptors.氧化型低密度脂蛋白与天然免疫受体
Curr Opin Lipidol. 2003 Oct;14(5):437-45. doi: 10.1097/00041433-200310000-00004.
4
Toll-like receptors in atherosclerosis.动脉粥样硬化中的Toll样受体
Biochem Soc Trans. 2007 Dec;35(Pt 6):1453-5. doi: 10.1042/BST0351453.
5
Multiple roles of Toll-like receptor signaling in atherosclerosis.Toll样受体信号通路在动脉粥样硬化中的多重作用。
Curr Opin Lipidol. 2006 Oct;17(5):527-33. doi: 10.1097/01.mol.0000245258.25387.ec.
6
TLRs are important inflammatory factors in atherosclerosis and may be a therapeutic target.Toll样受体(TLRs)是动脉粥样硬化中重要的炎症因子,可能成为一个治疗靶点。
Med Hypotheses. 2008;70(2):314-6. doi: 10.1016/j.mehy.2007.05.030. Epub 2007 Aug 6.
7
Quercetin regulates oxidized LDL induced inflammatory changes in human PBMCs by modulating the TLR-NF-κB signaling pathway.槲皮素通过调节 TLR-NF-κB 信号通路来调节氧化型 LDL 诱导的人 PBMCs 炎症变化。
Immunobiology. 2011 Mar;216(3):367-73. doi: 10.1016/j.imbio.2010.07.011. Epub 2010 Aug 19.
8
[Front line of oxidized lipoproteins: role of oxidized lipoproteins in atherogenesis and cardiovascular disease risk].[氧化型脂蛋白的前沿领域:氧化型脂蛋白在动脉粥样硬化形成及心血管疾病风险中的作用]
Rinsho Byori. 2010 Jun;58(6):622-30.
9
Treating atherosclerosis: the potential of Toll-like receptors as therapeutic targets.治疗动脉粥样硬化:Toll样受体作为治疗靶点的潜力
Expert Rev Cardiovasc Ther. 2010 Nov;8(11):1619-35. doi: 10.1586/erc.10.149.
10
The toll of Toll-like receptors, especially toll-like receptor 2, on murine atherosclerosis.Toll样受体,尤其是Toll样受体2,对小鼠动脉粥样硬化的影响。
Curr Drug Targets. 2007 Dec;8(12):1230-8. doi: 10.2174/138945007783220605.

引用本文的文献

1
Hidden features: CD36/SR-B2, a master regulator of macrophage phenotype/function through metabolism.隐藏特征:CD36/SR-B2,一种通过代谢调控巨噬细胞表型/功能的主要调节因子。
Front Immunol. 2024 Dec 17;15:1468957. doi: 10.3389/fimmu.2024.1468957. eCollection 2024.
2
Cholesteryl Hemiazelate Present in Cardiovascular Disease Patients Causes Lysosome Dysfunction in Murine Fibroblasts.胆固醇酰基溶血磷脂酸存在于心血管疾病患者中,导致小鼠成纤维细胞溶酶体功能障碍。
Cells. 2023 Dec 13;12(24):2826. doi: 10.3390/cells12242826.
3
The Impacts of Animal-Based Diets in Cardiovascular Disease Development: A Cellular and Physiological Overview.
动物性饮食对心血管疾病发展的影响:细胞与生理学概述
J Cardiovasc Dev Dis. 2023 Jun 30;10(7):282. doi: 10.3390/jcdd10070282.
4
LDL delivery of microbial small RNAs drives atherosclerosis through macrophage TLR8.LDL 递送的微生物小分子 RNA 通过巨噬细胞 TLR8 促进动脉粥样硬化。
Nat Cell Biol. 2022 Dec;24(12):1701-1713. doi: 10.1038/s41556-022-01030-7. Epub 2022 Dec 6.
5
Extracellular Vesicle Isolation and Characterization for Applications in Cartilage Tissue Engineering and Osteoarthritis Therapy.细胞外囊泡的分离与鉴定及其在软骨组织工程和骨关节炎治疗中的应用。
Methods Mol Biol. 2023;2598:123-140. doi: 10.1007/978-1-0716-2839-3_10.
6
Atherosclerosis Specific Features in Chronic Kidney Disease (CKD).慢性肾脏病(CKD)中的动脉粥样硬化特异性特征
Biomedicines. 2022 Aug 27;10(9):2094. doi: 10.3390/biomedicines10092094.
7
Olfactory receptor 2 in vascular macrophages drives atherosclerosis by NLRP3-dependent IL-1 production.血管巨噬细胞中的嗅觉受体 2 通过 NLRP3 依赖性的 IL-1 产生来驱动动脉粥样硬化。
Science. 2022 Jan 14;375(6577):214-221. doi: 10.1126/science.abg3067. Epub 2022 Jan 13.
8
Functional repertoire of EV-associated miRNA profiles after lipoprotein depletion via ultracentrifugation and size exclusion chromatography from autologous blood products.通过超速离心和大小排阻色谱法从自体血液产品中去除脂蛋白后,EV 相关 miRNA 谱的功能谱。
Sci Rep. 2021 Mar 12;11(1):5823. doi: 10.1038/s41598-021-84234-5.
9
Increasing the Chemical Variety of Small-Molecule-Based TLR4 Modulators: An Overview.增加基于小分子的 TLR4 调节剂的化学多样性:概述。
Front Immunol. 2020 Jul 10;11:1210. doi: 10.3389/fimmu.2020.01210. eCollection 2020.
10
Innate Immune Receptors, Key Actors in Cardiovascular Diseases.固有免疫受体,心血管疾病中的关键角色。
JACC Basic Transl Sci. 2020 Jul 27;5(7):735-749. doi: 10.1016/j.jacbts.2020.03.015. eCollection 2020 Jul.